TL
TowerView LLC’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Buy |
170,000
+42,500
| +33% | +$170K | 0.48% | 15 |
|
|
2025
Q1 | $405K | Buy |
127,500
+50,000
| +65% | +$159K | 0.29% | 21 |
|
|
2024
Q4 | $415K | Sell |
77,500
-40,000
| -34% | -$214K | 0.3% | 19 |
|
|
2024
Q3 | $620K | Sell |
117,500
-282,500
| -71% | -$1.49M | 0.4% | 17 |
|
|
2024
Q2 | $728K | Buy |
400,000
+17,500
| +5% | +$31.9K | 0.48% | 17 |
|
|
2024
Q1 | $681K | Sell |
382,500
-54,373
| -12% | -$96.8K | 0.45% | 16 |
|
|
2023
Q4 | $769K | Buy |
436,873
+94,395
| +28% | +$166K | 0.47% | 17 |
|
|
2023
Q3 | $500K | Buy |
342,478
+137,478
| +67% | +$201K | 0.33% | 18 |
|
|
2023
Q2 | $469K | Buy |
+205,000
| New | +$469K | 0.31% | 19 |
|